Trials / Unknown
UnknownNCT04446390
Preventive Regimens With Herbal and Fluoride Toothpaste on Remineralization in High Caries Patients With Initial Lesions
Evaluation of Remineralization Potential of Preventive Regimens Containing Herbal-based Compared to Fluoride-based Toothpastes in High Caries Risk Patients With Initial Carious Lesions: Randomized Clinical Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 15 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This study will be conducted to assess the effect of different preventive regimens using herbal toothpaste versus fluoride toothpaste on the management of remineralization and caries risk in high caries risk patients.
Detailed description
Dental caries is a major universal health problem with multiple etiological factors, so looking for economical and accurate plans for recognizing high-risk persons, and multiple risk factors to reduce the risk, in addition to caries management, using a caries risk assessment to detect the person who will develop caries, and provide them with suitable preventive and treatment regimens to disruption the disease procedure. The treatment should evade invasive treatments and a large emphasis on prevention (using fluoride toothpaste, solutions, patient education, and so on), to achieve the aim of new dentistry (minimal intervention). The application of such a regimen to manage initial caries lesions allows the dentist to reverse initial lesions with the minimal victim of healthy dental tissues.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Himalaya complete care toothpaste | Herbal toothpaste as a part of a caries preventive regimen |
| OTHER | colgate cavity protection | fluoride toothpaste as a part of a caries preventive regimen |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2022-03-01
- Completion
- 2022-03-01
- First posted
- 2020-06-24
- Last updated
- 2022-02-03
Locations
2 sites across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04446390. Inclusion in this directory is not an endorsement.